A Gujarat-based man has shared a moving account of a late-night ride that revealed the quiet sacrifices made by working-class families. “The kind of India we ignore,” read the title of the post shared on the r/India subreddit that has triggered conversations about struggles that often go unnoticed in everyday life. In the post, the … Read more
An exercise programme for colon cancer patients can cut the risk of dying by a third, a major international trial shows. The researchers said it was “not a large amount” of exercise and any type of workout from swimming to salsa classes counted. The results could change the way colon cancer is treated around the … Read more
Philippa Roxby Heath Reporter Laura Marston Laura now feels good six years after her diagnosis of advanced tongue cancer Hundreds of thousands of people with advanced head and neck cancer could live longer without their cancer returning thanks to an immunotherapy drug, a clinical trial suggests. This is the first sign of a breakthrough for … Read more
Washington: Doctors often start exams with the so-called “eyeball test” — a snap judgment about whether the patient appears older or younger than their age, which can influence key medical decisions. That intuitive assessment may soon get an AI upgrade. FaceAge, a deep learning algorithm described Thursday in The Lancet Digital Health, converts a simple … Read more
Jon Shelton, head of cancer intelligence at Cancer Research UK, said: “This report shows us where the UK is doing well, and where we need to focus on improvements for patients. There are positives in here – screening is having a real impact, and cancer mortality rates are falling. Source link
Data suggests Wales ranks 32nd out of 33 similarly wealthy nations for surviving stomach cancer. Source link
Washington: According to a new study, A new artificial intelligence model can bring much-needed clarity to doctors delivering prognoses and deciding on treatments for patients with colorectal cancer, the second deadliest cancer worldwide. The study was published in the journal, ‘Nature Communications’. The new tool accurately predicts how aggressive a colorectal tumor is, how likely … Read more
By Amy Norton HealthDay Reporter THURSDAY, July 21, 2022 (HealthDay News) — Adding the drug Keytruda to standard chemotherapy can extend the lives of some women with an aggressive form of breast cancer, a new study finds. The study involved women with advanced triple-negative breast cancer, a hard-to-treat form of the disease. Keytruda (pembrolizumab) is … Read more
By Cara Murez HealthDay Reporter MONDAY, May 23, 2022 (HealthDay News) — If you’re poor and have a severe type of heart attack, the chance you’ll live through it is significantly lower than that of someone with more money, new research shows. The finding underscores the need to close a divide in health care that … Read more
By Denise Mann HealthDay Reporter MONDAY, Sept. 20, 2021 (HealthDay News) — New research offers good news for women with an aggressive HER2-positive breast cancer. A targeted therapy, trastuzumab deruxtecan (T-DXd), sold as Enhertu, triples the length of time that the cancer remains in check when compared with the current gold standard, trastuzumab emtansine (T-DM1). … Read more